Assessing the Potential Patient Care Implications of New Data in Eosinophilic Esophagitis: Clinical Transfers®

Program Overview

In this activity, 2 experts in the diagnosis and management of eosinophilic esophagitis (EoE) analyze data on the treatment of this disease that was presented at the 2021 Digestive Disease Week virtual meeting. Topics for discussion include updates on current management approaches for EoE, new research highlighting the pathophysiological underpinnings of EoE, and late-breaking data on emerging treatment approaches for individuals with EoE.

Credit Expired
0.50 CE Credit(s)
Expires: July 13, 2022

Target Audience

Gastroenterologists, pediatric gastroenterologists, allergy/immunologists, pediatric allergy/immunologists, and other healthcare professionals involved in the treatment of patients with eosinophilic esophagitis (EoE).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Assess recently presented data on current approaches for the management of eosinophilic esophagitis (EoE)
  • Summarize new findings related to immune pathophysiologic pathways and therapeutic targets for EoE
  • Analyze late-breaking data related to the efficacy, safety, and tolerability of new and emerging therapies for treatment of EoE

Activity Faculty

Dr. Dellon photo

Evan S. Dellon, MD, MPH (Chair)

Professor, Medicine
Adjunct Professor, Epidemiology
University of North Carolina School of Medicine
Chapel Hill, NC


Amanda B. Muir, MD, MTR

Attending Physician
Children’s Hospital of Philadelphia, Research Institute
Philadelphia, PA

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

© Copyright 2023. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | | (866) 770-RMEI


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources